Sensitive glucagon quantification by immunochemical and LC-MS/MS methods

Bioanalysis

Volumn 5, Issue 23, 2013, Pages 2957-2972

  Lapko, Veniamin N ^a   Miller, Patrick S ^a   Brown, G Paul ^a   Islam, Rafiqul ^a   Peters, Sarah K ^a   Sukovaty, Richard L ^a   Ruhn, Peggy F ^a   Kafonek, Chris J ^a  

^a CELERION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON;

ACIDIFICATION; AMINO ACID SEQUENCE; ANTIBODY DETECTION; CARBOXY TERMINAL SEQUENCE; COLORIMETRY; GENETIC TRANSCRIPTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOCHEMISTRY; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MUTAGENESIS; PEPTIDE ANALYSIS; PHYSICAL CHEMISTRY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEOMICS; RADIOIMMUNOASSAY; REVIEW; TANDEM MASS SPECTROMETRY;

AMINO ACID SEQUENCE; ANIMALS; CHROMATOGRAPHY, LIQUID; GLUCAGON; HUMANS; IMMUNOASSAY; MOLECULAR SEQUENCE DATA; TANDEM MASS SPECTROMETRY;

EID: 84890418271     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.264     Document Type: Review

References (68)

1. Center for Disease Control and Prevention. Diabetes Report Card 2012. Center for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Diabetes Translation, Atlanta, GA, USA (2012
2. Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am. J. Physiol. 284(4), E671-E678 (2003
3. Cryer PE. Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes. Endocrinology 153(3), 1039-1048 (2012
4. Pocai A. Unraveling oxyntomodulin, GLP1s enigmatic brother. J. Endocrinol. 215(3), 335-346 (2012
5. Authier F, Desbuquois B. Glucagon receptors. Cell. Mol. Life Sci. 65(12), 1880-1899 (2008
6. Habegger KM, Heppner KM, Geary N, Bartness TJ, DiMarchi R, Tschöp MH. The metabolic actions of glucagon revisited. Nat. Rev. Endocrinol. 6(12), 689-697 (2010
7. Jones BJ, Tan T, Bloom SR. Minireview: Glucagon in stress and energy homeostasis. Endocrinology 153(3), 1049-1054 (2012
8. EMD Millipore. Application Note: Specific Detection of Full-length Glucagon From Blood Samples Using a Chemiluminescent ELISA Kit (AN4993EN00-EM). EMD Millipore Corporation. Billerica, MA USA (2012
9. Alford FP, Bloom SR, Nabarro JDN. Glucagon levels in normal and diabetic subjects: Use of a specific immunoabsorbent for glucagon radioimmunoassay. Diabetologia 13(1), 1-6 (1977
10. Lapko VN. Quantitative LC-MS/MS analysis of polypeptides: Glucagon. Presented at: EBS Focus Meeting: Large Meets Small. Brussels, Belgium, 21-22 June 2011
11. Sasaki K, Dockerill S, Adamiak DA, Tickle IJ, Blundell T. X-ray analysis of glucagon and its relationship to receptor binding. Nature 257(5529), 751-757 (1975
12. van den Broek I, Sparidans RW, Schellens JHM, Beijnen JH. Quantitative bioanalysis of peptides by liquid chromatography coupled to (tandem) mass spectrometry. J. Chromatogr. B 872(1-2), 1-22 (2008
13. Rodríguez-Cabaleiro D, Van Uytfanghe K, Stove V, Fiers T, Thienpont LM. Pilot study for the standardization of insulin immunoassays with isotope dilution liquid chromatography/tandem mass spectrometry. Clin. Chem. 53(8), 1462-1469 (2007
14. Krastins B, Prakash A, Sarracino DA et al. Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum. Clin. Biochem. 46(6), 399-410 (2013
15. Prestrelski SJ, Kinzell J. Soluble non-aqueous glucagon formulations for the treatment of severe hypoglycemia. Presented at: American Diabetes Association 72nd Scientific Sessions. Philadelphia, PA, USA, 8-12 June 2012
16. Alford FP, Bloom SR, Nabarro JD. Glucagon metabolism in man, studies on the metabolic clearance rate and the plasma acute disappearance time of glucagon in normal and diabetic subjects. J. Clin. Endocrinol. Metab. 42(5), 830-838 (1976
17. Jaspan JB, Polonsky KS, Lewis M et al. Hepatic metabolism of glucagon in the dog: Contribution of the liver to overall metabolic disposal of glucagon. Am. J. Physiol. 240(3), E233-E244 (1981
18. Pospisilik JA, Hinke SA, Pederson RA et al. Metabolism of glucagon by dipeptidyl peptidase IV (CD26). Regul. Pept. 96(3), 133-141 (2001
19. BD™. BD™ P800 Blood Collection System for Preservation of Plasma GLP-1, GIP, Glucagon, and Ghrelin. Enabling Metabolic Biomarker Preservation. Becton, Dickinson and Company, Franklin Lakes, NJ, USA (2009
20. Sloan JH, Siegel RW, Ivanova-Cox YT, Watson DE, Deeg MA, Konrad RJ. A novel high-sensitivity electrochemiluminescence (ECL) sandwich immunoassay for the specific quantitative measurement of plasma glucagon. Clin. Biochem. 45(18), 1640-1644 (2012
21. Unger RH, Eisentraut AM, McCall MS, Madison LL. Glucagon antibodies and an immunoassay for glucagon. J. Clin. Invest. 40, 1280-1289 (1961
22. Heding LG. Radioimmunological determination of pancreatic and gut glucagon in plasma. Diabetologia 7(1), 10-19 (1971
23. von Schenck H, Nilsson OR. Radioimmunoassay of extracted glucagon compared with three non-extraction assays. Clin. Chim. Acta 109(2), 183-191 (1981
24. Soybel D, Jaspan J, Polonsky K, Goldberg I, Rayfield E, Tager H. Differential immunoreactivity of plasma glucagon components in man: Studies with different glucagon antibodies. J. Clin. Endocrinol. Metabol. 56(3), 612-618 (1983
25. R&D Systems, Inc. Quantikine® ELISA Glucagon Immunoassay, Catalog Number DGCG0. For the Quantitative Determination of Glucagon Concentrations in Cell Culture Supernates, Serum, and Plasma. R&D Systems, Inc., Minneapolis, MN, USA (2011
26. EMD Millipore Corporation. Glucagon Chemiluminescent ELISA Kit, 96-Well Plate (Cat # EZGLU-30K). EMD Millipore Corporation, St. Charles, MO, USA (2012
27. Millipore. Glucagon RIA Kit, 250 Tubes (Cat. # GL-32K). Millipore, St. Charles, MO, USA (2011
28. ALPCO Diagnostics. Glucagon RIA: For the Quantitative Determination of Glucagon in Plasma. ALPCO Diagnostics, Salem, NH, USA (2011
29. Stevenson LF. Biomarker assay development and validation for large molecules in bioanalysis: What are the challenges and how are they overcome? Bioanalysis 4(22), 2657-2659 (2012
30. Fierens C, Stöckl D, Baetens D, De Leenheer AP, Thienpont LM. Standardization of C-peptide measurements in urine by method comparison with isotope-dilution mass spectrometry. Clin. Chem. 49(6 Pt 1), 992-994 (2003
31. Manley SE, Stratton IM, Clark PM, Luzio SD. Comparison of 11 human insulin assays: Implications for clinical investigation and research. Clin. Chem. 53(5), 922-932 (2007
32. Haisenleder DJ, Schoenfelder AH, Marcinko ES, Geddis LM, Marshall JC. Estimation of estradiol in mouse serum samples: Evaluation of commercial estradiol immunoassays. Endocrinology 152(11), 4443-4447 (2011
33. Marks V. False-positive immunoassay results: A multicenter survey of erroneous immunoassay results from assay of 74 analytes in donors from 66 laboratories in seven countries. Clin. Chem. 48(11), 2008-2016 (2002
34. Lame ME, Chambers EE, Blatnik M. Quantitation of amyloid beta peptides Ab1-38, Ab1-40, and Ab1-42 in human cerebrospinal fluid by ultra-performance liquid chromatography-tandem mass spectrometry. Anal. Biochem. 419, 133-139 (2011
35. Halquist MS, Sakagami M, Karnes HT. Determination of oxyntomodulin, an anorectic polypeptide, in rat plasma using 2D-LC-MS/MS coupled with ion pair chromatography. J. Chromatogr. B 903, 102-111 (2012
36. Bailly-Chouriberry L, Cormant F, Garcia P, Kind A, Popot M-A, Bonnaire Y. Identification of a-cobratoxin in equine plasma by LC-MS/MS for doping control. Anal. Chem. 85(10), 5219-5225 (2013
37. Lövgren U, Johansson S, Jensen LS, Ekström C, Carlshaf A. Quantitative determination of peptide drug in human plasma samples at low pg/ml levels using coupled column liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 53(3), 537-545 (2010
38. Hosogi J, Tanaka H, Fujita K et al. LC-MS/MS coupled with immunoaffinity extraction for determination of estrone, 17beta-estradiol and estrone 3-sulfate in human plasma. J. Chromatogr. B 878(2), 222-227 (2010
39. Whiteaker JR, Zhao L, Zhang HY et al. Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Anal. Biochem. 362(1), 44-54 (2007
40. Blackburn M. Quantitation of a therapeutic insulin analogue by immuno-affinity extraction LC-MS/MS. Presented at: 5th EBF Open Symposium. Barcelona, Spain, 16-18 November 2012
41. Wolf R, Hoffmann T, Rosche F, Demuth H-U. Simultaneous determination of incretin hormones and their truncated forms from human plasma by immunoprecipitation and liquid chromatography-mass spectrometry. J. Chromatogr. B 803(1), 91-99 (2004
42. Van Uytfanghe K, Rodríguez-Cabaleiro D, Stöckl D, Thienpont LM. New liquid chromatography/electrospray ionisation tandem mass spectrometry measurement procedure for quantitative analysis of human insulin in serum. Rapid Commun. Mass Spectrom. 21(5), 819-821 (2007
43. Chen Z, Caufield MP, McPhaul MJ, Reitz RE, Taylor SW, Clarke NJ. Quantitative insulin analysis using liquid chromatography-tandem mass spectrometry in a high-throughput clinical laboratory. Clin. Chem. 59(9), 1349-1356 (2013
44. Delinsky DC, Hill KT, White CA, Bartlett MG. Quantitation of the large polypeptide glucagon by protein precipitation and LC/MS. Biomed. Chromatogr. 18(9), 700-705 (2004
45. Higashi T, Shimada K. Derivatization of neutral steroids to enhance their detection characteristics in liquid chromatography-mass spectrometry. Anal. Bioanal.Chem. 378(4), 875-882 (2004
46. Schnier PD, Gross DS, Williams ER. On the maximum charge state and proton transfer reactivity of peptide and protein ions formed by electrospray ionization. J. Am. Soc. Mass Spectrom. 6(11), 1086-1097 (1995
47. Hewavitharana AK, Herath HMDR, Shaw PN, Cabot PJ, Kebarle P. Effect of solvent and electrospray mass spectrometer parameters on the charge state distribution of peptides - a case study using liquid chromatography/mass spectrometry method development for beta-endorphin assay. Rapid Commun. Mass Spectrom. 24(24), 3510-3514 (2010
48. Valeja SG, Tipton JD, Emmett MR, Marshall AG. New reagents for enhanced liquid chromatographic separation and charging of intact protein ions for electrospray ionization mass spectrometry. Anal. Chem. 82(17), 7515-7519 (2010
49. Johnson RS, Martin SA, Biemann K. Collision-induced fragmentation of (M + H)+ ions of peptides. Side chain specific sequence ions. Int. J. Mass Spectrom. Ion Process 86, 137-154 (1988
50. Breci LA, Tabb DL, Yates JR, Wysocki VH. Cleavage N-terminal to proline: Analysis of a database of peptide tandem mass spectra. Anal. Chem. 75(9), 1963-1971 (2003
51. Maux D, Enjalbal C, Martinez J, Aubagnac J-L. New example of proline-induced fragmentation in electrospray ionization mass spectrometry of peptides. Rapid Commun. Mass Spectrom. 16(15), 1470-1475 (2002
52. Xu Y, Gutierrez JP, Lu T-S et al. Quantitation of exenatide in human plasma using LC-MS/MS/MS (LC-MS3) on a linear Q-Trap API-5500 system. Presented at: 57th ASMS Conference on Mass Spectrometry and Allied Topics. Philadelphia, PA, USA,31 May-4 June 2009
53. Knudsen CB. Immunoaffinity - LC-MS/MS in peptide bioanalysis. Presented at: 2nd Nordic MS Symposium. Bastad, Sweden, 8-9 November 2011
54. Li Y-X, Hackman M, Wang C-Y. Quantitation of polypeptides (glucagon and salmon calcitonin) in plasma samples by 'high resolution' on a triple quadrupole mass spectrometer. Bioanalysis 4(6), 685-691 (2012
55. Morin L-P, Mess J-N, Garofolo F. Large-molecule quantification: Sensitivity and selectivity head-to-head comparison of triple quadrupole with Q-TOF. Bioanalysis 5(10), 1181-1193 (2013
56. Lapko V, Brown P, Nachi R et al. Exploring quantification of peptides: Measurement of glucagon in human plasma by LC-MS/MS. Presented at: EBF 3rd Annual Open Symposium: From Challenges to Solutions. Barcelona, Spain, 1-3 December 2010
57. Mess J-N, Morin L-P, Aiello M et al. Glucagon bioanalysis by LC-MS: Unprecedented level of sensitivity (10 pg/ml) for a novel formulation. Presented at: 2013 American Association of Pharmaceutical Scientists National Biotechnology Conference. San Diego, CA, USA, 20-22 May 2013
58. Dillen L, Cools W, Vereyken L et al. Comparison of triple quadrupose and high resolution FOT-MS for quasntitation peptides. Bioanalysis 4(5), 565-579 (2012
59. Hoofnagle AN, Wener MH. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J. Immunol. Methods 347(1-2), 3-11 (2009
60. Oldfield P. Ligand-binding assays: Old challenges, new solutions. Bioanalysis 3(6), 571-573 (2011
61. Kay RG, Roberts A. Bioanalysis of biotherapeutic proteins and peptides: Immunological or MS approach? Bioanalysis 4(8), 857-860 (2012
62. Shackman JG, Reid KR, Dugan CE, Kennedy RT. Dynamic monitoring of glucagon secretion from living cells on a microfluidic chip. Anal. Bioanal. Chem. 402(9), 2797-2803 (2012
63. Nicholson R, Lowes S, Caturla MC et al. Conference report: 6th GCC focus on LBA: Critical reagents, positive controls and reference standards; specificity for endogenous compounds; biomarkers; biosimilars. Bioanalysis 4(19), 2335-2342 (2012
64. van de Merbel NC, Bronsema KJ, Nemansky M. Protein quantification using LC-MS: Can it make a difference? Bioanalysis 4(17), 2113-2116 (2012
65. Faupel-Badger JM, Fuhrman BJ, Xu X et al. Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens. Cancer Epidemiol. Biomarkers Prev. 19(1), 292-300 (2010
66. Monaghan PJ, Owen LJ, Trainer PJ, Brabant G, Keevil BG, Darby D. Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11b-hydroxylase inhibitor metyrapone. Ann. Clin. Biochem. 48(50), 441-446 (2011
67. Baid SK, Sinaii N, Wade M, Rubino D, Nieman LK. Radioimmunoassay and tandem mass spectromerty measurement of bedtime salvaroty cortisol levels: A comparison of assays to establish hypercortisolism. J. Clin. Endocrinol. Metab. 92(8), 3102-3107 (2007
68. Haring R, Baumeister SE, Nauck M et al. Testosterome and cardiometabolic risk in the general population - the impact of measurement method on risk assoociations: A comparative study between immunoassay and mass spectrometry. Eur. J. Endocrinol. 169(4), 463-470 (2013